Page last updated: 2024-10-31

nafronyl and Glioma

nafronyl has been researched along with Glioma in 1 studies

Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kempski, O1
Chaussy, L1
Gross, U1
Zimmer, M1
Baethmann, A1

Other Studies

1 other study available for nafronyl and Glioma

ArticleYear
Volume regulation and metabolism of suspended C6 glioma cells: an in vitro model to study cytotoxic brain edema.
    Brain research, 1983, Nov-21, Volume: 279, Issue:1-2

    Topics: Brain Edema; Brain Neoplasms; Cell Line; Culture Techniques; Energy Metabolism; Flow Cytometry; Glio

1983
chemdatabank.com